AURA

$5.98

$

Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.

Next Earnings

2026-02-25

Beta

0.457

Average Volume

Market Cap

Last Dividend

CIK

0001501796

ISIN

US05153U1079

CUSIP

05153U107

CEO

Elisabet de los Pinos

Sector

Healthcare

Industry

Biotechnology

Full Time Employees

106

IPO Date

2021-10-29

Status

Active

Latest News

Title Headline Publisher Date
What Makes Aura Biosciences (AURA) a New Buy Stock Aura Biosciences (AURA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Zacks Investment Research 2026-02-13 13:01:04
Permanent Capital Management LP Makes New Investment in Aura Biosciences, Inc. $AURA Permanent Capital Management LP bought a new position in shares of Aura Biosciences, Inc. (NASDAQ: AURA) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 147,769 shares of the company's stock, valued at approximately $913,000. Permanent Capital Management LP Defense World 2025-12-29 06:15:02

SEC Filings

Type Filing Date Accepted Date Link
SC 13G/A 2026-02-17 2026-02-17 View Filing
4 2026-02-17 2026-02-17 View Filing
4 2026-02-17 2026-02-17 View Filing
4 2026-02-17 2026-02-17 View Filing
4 2026-02-17 2026-02-17 View Filing
4 2026-02-17 2026-02-17 View Filing
SC 13G/A 2026-02-13 2026-02-13 View Filing
4 2026-01-20 2026-01-20 View Filing
4 2026-01-20 2026-01-20 View Filing
4 2025-11-17 2025-11-17 View Filing
10-Q 2025-11-13 2025-11-13 View Filing
8-K 2025-11-13 2025-11-13 View Filing
4 2025-10-29 2025-10-29 View Filing
4 2025-10-29 2025-10-29 View Filing
SC 13G 2025-10-17 2025-10-17 View Filing
4 2025-10-16 2025-10-16 View Filing
4 2025-08-18 2025-08-18 View Filing
SC 13G/A 2025-08-14 2025-08-14 View Filing
SC 13G/A 2025-08-13 2025-08-13 View Filing
10-Q 2025-08-13 2025-08-13 View Filing
8-K 2025-08-13 2025-08-13 View Filing
SC 13G/A 2025-07-16 2025-07-16 View Filing
4 2025-06-18 2025-06-18 View Filing
4 2025-06-18 2025-06-18 View Filing
4 2025-06-18 2025-06-18 View Filing
8-K 2025-06-18 2025-06-18 View Filing
4 2025-06-04 2025-06-04 View Filing
4 2025-06-04 2025-06-04 View Filing
SC 13G 2025-05-23 2025-05-23 View Filing
4 2025-05-20 2025-05-20 View Filing
4 2025-05-20 2025-05-20 View Filing
SC 13D/A 2025-05-19 2025-05-19 View Filing
3 2025-05-16 2025-05-16 View Filing
8-K 2025-05-16 2025-05-16 View Filing
424B5 2025-05-16 2025-05-16 View Filing
SC 13G/A 2025-05-15 2025-05-15 View Filing
424B5 2025-05-15 2025-05-15 View Filing
10-Q 2025-05-15 2025-05-15 View Filing
8-K 2025-05-15 2025-05-15 View Filing
SC 13G/A 2025-05-14 2025-05-14 View Filing
SC 13G/A 2025-05-13 2025-05-13 View Filing
ARS 2025-04-24 2025-04-24 View Filing
DEFA14A 2025-04-24 2025-04-24 View Filing
DEF 14A 2025-04-24 2025-04-24 View Filing
4 2025-04-16 2025-04-16 View Filing
4 2025-04-16 2025-04-16 View Filing
SC 13G 2025-04-11 2025-04-11 View Filing
4 2025-04-02 2025-04-02 View Filing
3 2025-04-02 2025-04-02 View Filing
8-K 2025-04-02 2025-04-02 View Filing
S-8 2025-03-24 2025-03-24 View Filing
10-K 2025-03-24 2025-03-24 View Filing
8-K 2025-03-24 2025-03-24 View Filing
4 2025-02-18 2025-02-18 View Filing
4 2025-02-18 2025-02-18 View Filing
4 2025-02-18 2025-02-18 View Filing
4 2025-02-18 2025-02-18 View Filing
SC 13G/A 2025-02-14 2025-02-14 View Filing
4 2025-02-04 2025-02-04 View Filing
4 2025-02-04 2025-02-04 View Filing
4 2025-02-04 2025-02-04 View Filing
4 2025-02-04 2025-02-04 View Filing
4 2025-02-04 2025-02-04 View Filing
4 2025-01-21 2025-01-21 View Filing
4 2025-01-21 2025-01-21 View Filing
SC 13G/A 2025-01-03 2025-01-03 View Filing
SC 13G 2025-01-03 2025-01-03 View Filing
4 2024-11-18 2024-11-18 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
SC 13G/A 2024-11-14 2024-11-14 View Filing
10-Q 2024-11-12 2024-11-12 View Filing
8-K 2024-11-12 2024-11-12 View Filing
SC 13G/A 2024-11-12 2024-11-12 View Filing
SC 13G 2024-11-08 2024-11-08 View Filing
4 2024-10-29 2024-10-29 View Filing
4 2024-10-29 2024-10-29 View Filing
3 2024-10-29 2024-10-29 View Filing
SC 13G 2024-10-22 2024-10-22 View Filing
4 2024-10-21 2024-10-21 View Filing
4 2024-10-18 2024-10-18 View Filing
8-K 2024-10-17 2024-10-17 View Filing
4 2024-10-16 2024-10-16 View Filing
4 2024-10-01 2024-10-01 View Filing
8-K 2024-09-27 2024-09-27 View Filing
8-K 2024-09-12 2024-09-12 View Filing
10-Q 2024-08-08 2024-08-08 View Filing
8-K 2024-08-08 2024-08-08 View Filing
4 2024-06-24 2024-06-24 View Filing
4 2024-06-24 2024-06-24 View Filing
4 2024-06-24 2024-06-24 View Filing
8-K 2024-06-21 2024-06-21 View Filing
DEFA14A 2024-06-14 2024-06-14 View Filing
10-K/A 2024-06-14 2024-06-14 View Filing
8-K 2024-06-04 2024-06-04 View Filing
10-Q 2024-05-09 2024-05-09 View Filing
8-K 2024-05-09 2024-05-09 View Filing
ARS 2024-04-25 2024-04-25 View Filing
DEFA14A 2024-04-25 2024-04-25 View Filing
DEF 14A 2024-04-25 2024-04-25 View Filing
8-K 2024-04-15 2024-04-15 View Filing

Algorithm Performance

Upgrade To Premium for Full Access
Algorithm Profit/Loss Profit Factor # Trades Sharpe Sortino Efficiency
Bollinger Bands Strategy 59.36% 1.04 62 0.07 0.32 57.9
Swarm Intelligence Strategy 54.80% 1 654 0.04 0.11 53.34
Williams PercentR Strategy 37.59% 1 277 0.04 0.16 36.13
xxxxxxxxxxxxxx xxxxxxx% x xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx xxxx xxxx xxxxx
xxxxxxxxxx xxxxxxx% x xxx xxxx xxxx xxxxx
xxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxx xxxx xxxxx
xxxxxxxxxxxxx xxxxxxx% xxxx xxx xxxx xxxx xxxx
xxxxxxxxxxxxxxxx xxxxxxx% xxx xx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% x xxx xxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxxxxx xxxxxxx% xxxx x xxxx xxxx xxxx
xxxxxxxxxx xxxxxxx% xxxx xxx x xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxx% xxxx xxx xxxxx xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx x% x xxx x x xxxx
xxxxxxxxxxxxxxxxx xxxxxxx% xxxx xx xxxxx x xxx
xxxxxxxxxxxxxxxxxxxxxxxx xxxxxxx% xxxx xxx xxxxx x xxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx x x xxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx x x xxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx x xxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxx xxxxxxxx% x xxx xxxxx x xxxx
xxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxx
xxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxx xxxxxxxx% x xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx
xxxxxxxxxxxxxxxxxxxxx xxxxxxxx% xxxx xxx xxxxx xxxxx xxxxx